Despite reports of errors using the da Vinci system, Intuitive Surgical has put up good numbers so far. Total procedures rose 25% in the fourth quarter and 29% in last year's first quarter. The company sold 175 and 140 da Vinci systems, respectively, during those periods.
For its part, Wall Street is expecting revenue to grow 17.7% to $582.9 million, resulting in $3.99 of profit per share. The company has beat earnings estimates in each of the past four quarters, according to data supplied by Yahoo! Finance. Intuitive Surgical stock is still down nearly 6% over that period.
Would another beat send Intuitive Surgical stock soaring? Tim Beyers of Motley Fool Rule Breakers and Motley Fool Supernova weighs in on this question in the video below. Please watch and then leave a comment to let us know what you whether you would buy, sell, or short Intuitive Surgical stock at current prices.
Fool contributor Tim Beyers is a member of the Motley Fool Rule Breakers stock-picking team and the Motley Fool Supernova Odyssey I mission. He didn't own shares in any of the companies mentioned in this article at the time of publication. Check out Tim's web home and portfolio holdings or connect with him on Google+, Tumblr, or Twitter, where he goes by @milehighfool. You can also get his insights delivered directly to your RSS reader.
Motley Fool newsletter services have recommended buying shares of Intuitive Surgical. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.